Telemedicine for Multidisciplinary Urologic Cancer Care: A Prospective Single Institution Study.
Document Type
Article
Publication Date
6-2024
Publication Title
Clinical genitourinary cancer
Abstract
BACKGROUND: We rapidly implemented a telemedicine Multidisciplinary Urologic Cancer Clinic (MDUCC) at the University of Washington/Seattle Cancer Care Alliance during the peak of the COVID-19 Public Health Emergency to maintain our ability to provide multidisciplinary cancer care. We report our experiences though assessment of patient-reported outcomes from our telemedicine MDUCC.
METHODS: Video visits with a urologic oncologist, medical oncologist, and radiation oncologist were conducted in the same format as our in-person MDUCC. We prospectively collected patient demographic and clinical data. Patients were invited to complete a post-visit survey that assessed satisfaction, provider trust, travel time, and costs of the telemedicine visit. We estimated travel distances and times from each patient's home to our clinic.
RESULTS: Among invited patients, twenty-four patients completed a survey after their telemedicine MDUCC visit. Twenty patients (83%) were at home during the visit. Most (85%) were men, Caucasian (79%), and were being seen in our Bladder Cancer MDUCC (83%). All twenty-four patients responded that they would be willing to have future appointments via telemedicine; eighteen patients (75%) strongly agreed that the encounter was high quality; 19 patients strongly agreed that they were satisfied with their visit. Patients saved an estimated average one-way travel distance of 145 miles and one-way travel time of 179 minutes to convene a telemedicine visit.
CONCLUSIONS: Telemedicine MDUCCs are feasible and effective in providing access to multidisciplinary urologic cancer care. Patient satisfaction was high, and many patients were spared a substantial travel burden. Telemedicine may continue to be leveraged to improve access to multidisciplinary urologic cancer care.
Volume
22
Issue
3
First Page
102058
Recommended Citation
Okoye F, Gadzinski AJ, Sekar R, Abarro I, Grivas P, Tykodi SS, et al Telemedicine for multidisciplinary urologic cancer care: a prospective single institution study. Clin Genitourin Cancer. 2024 Jun;22(3):102058. doi: 10.1016/j.clgc.2024.02.009. PMID: 38537419.
DOI
10.1016/j.clgc.2024.02.009
ISSN
1938-0682
PubMed ID
38537419